Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy

•Advanced age and stage and increased bolus retention are risk factors for aspiration.•Patients with ≥ 2 risk factors are 2.5 times more likely to aspirate post-radiation.•Quantitative measures of swallowing are highly predictive of aspiration events. To determine characteristics most strongly assoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2023-01, Vol.136, p.106247-106247, Article 106247
Hauptverfasser: Liu, Hannah C., Williamson, Casey W., Zou, Jingjing, Todd, Jacob R., Nelson, Tyler J., Hill, Lindsay M., Linnemeyer, Kristen E., Henderson, Gerald, Madgula, Puja, Faung, Brian, Sacco, Assuntina G., Vitzthum, Lucas K., Weissbrod, Philip A., Blumenfeld, Liza S., Mell, Loren K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Advanced age and stage and increased bolus retention are risk factors for aspiration.•Patients with ≥ 2 risk factors are 2.5 times more likely to aspirate post-radiation.•Quantitative measures of swallowing are highly predictive of aspiration events. To determine characteristics most strongly associated with risk for aspiration events among head and neck cancer (HNC) patients undergoing curative intent treatment. This was a retrospective, cross-sectional study of 106 patients with previously untreated HNC who received definitive or postoperative radiation therapy (RT) +/− systemic therapy with curative intent. Patients who received post-treatment videofluoroscopic swallow study (VFSS) between 2018-2021 were included. Using ordinal multivariable logistic regression, we modeled the effects of age (>60 years vs. ≤60 years), sex, body mass index (BMI) (>20 kg/m2 vs. ≤20 kg/m2), American Joint Committee on Cancer 8th edition stage (I-II vs. III-IVB), treatment with cisplatin (vs. other or no systemic therapy), post-operative status, primary site (oral cavity vs. P16+ oropharynx vs. P16- Mucosal Site vs. other), and quantitative VFSS measures on Penetration-Aspiration Scale (PAS) score. On ordinal multivariable logistic regression, age >60 years (odds ratio (OR): 3.91, 95% confidence interval (CI): 1.29, 11.9), advanced stage (stage III-IVB) (OR: 3.13, 95% CI: 1.23, 7.79), pharyngeal constriction ratio (PCR) >0.25 (OR: 3.65, 95% CI: 1.14, 11.7), and bolus clearance ratio (BCR) > 0.10 (OR: 3.42, 95% CI: 1.20, 9.75) were found to be significant risk factors for higher PAS scores. Patients with ≥ 2 pre-treatment risk factors had statistically significant increased risk for post-treatment aspiration (OR 2.52, 95% CI: 1.31, 4.86) on ordinal logistic regression. This model could be useful to direct high-risk patients toward interventions designed to reduce risk of aspiration events.
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2022.106247